Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A common variant associated with prostate cancer in European and African populations


With the increasing incidence of prostate cancer, identifying common genetic variants that confer risk of the disease is important. Here we report such a variant on chromosome 8q24, a region initially identified through a study of Icelandic families. Allele −8 of the microsatellite DG8S737 was associated with prostate cancer in three case-control series of European ancestry from Iceland, Sweden and the US. The estimated odds ratio (OR) of the allele is 1.62 (P = 2.7 × 10−11). About 19% of affected men and 13% of the general population carry at least one copy, yielding a population attributable risk (PAR) of 8%. The association was also replicated in an African American case-control group with a similar OR, in which 41% of affected individuals and 30% of the population are carriers. This leads to a greater estimated PAR (16%) that may contribute to higher incidence of prostate cancer in African American men than in men of European ancestry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A schematic view of the linkage and association results, marker density and LD structure in a region on chromosome 8q24.21.
Figure 2: RNA expression of identified splice variants derived from the EST AW 183883.

Similar content being viewed by others

Accession codes




  1. Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).

    Article  PubMed  Google Scholar 

  2. Amundadottir, L.T. et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1, e65 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Crawford, E.D. Epidemiology of prostate cancer. Urology 62, 3–12 (2003).

    Article  PubMed  Google Scholar 

  4. NIH Pub. No. 99–4649. Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995 (US National Cancer Institute, SEER Program, Bethesda, Maryland, 1999).

  5. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000).

    Article  CAS  PubMed  Google Scholar 

  6. Schaid, D.J. The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet. 13, R103–R121 (2004).

    Article  CAS  PubMed  Google Scholar 

  7. Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227–233 (1987).

    Article  CAS  PubMed  Google Scholar 

  8. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131–138 (2003).

    Article  CAS  PubMed  Google Scholar 

  9. Helgadottir, A. et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet. 38, 68–74 (2006).

    Article  CAS  PubMed  Google Scholar 

  10. Pritchard, J.K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945–959 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Pritchard, J.K., Stephens, M., Rosenberg, N.A. & Donnelly, P. Association mapping in structured populations. Am. J. Hum. Genet. 67, 170–181 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kent, W.J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Griffiths-Jones, S. The microRNA registry. Nucleic Acids Res. 32, D109–D111 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Baudis, M. & Cleary, M.L. an online repository for molecular cytogenetic aberration data. Bioinformatics 17, 1228–1229 (2001).

    Article  CAS  PubMed  Google Scholar 

  15. El Gedaily, A. et al. Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization. Prostate 46, 184–190 (2001).

    Article  CAS  PubMed  Google Scholar 

  16. Gulcher, J., Kong, A. & Stefansson, K. The genealogic approach to human genetics of disease. Cancer J. 7, 61–68 (2001).

    CAS  PubMed  Google Scholar 

  17. Gulcher, J.R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum. Genet. 8, 739–742 (2000).

    Article  CAS  PubMed  Google Scholar 

  18. Lindmark, F. et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J. Natl. Cancer Inst. 96, 1248–1254 (2004).

    Article  CAS  PubMed  Google Scholar 

  19. Beebe-Dimmer, J.L. et al. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men. Prostate Cancer Prostatic Dis. 9, 50–55 (2006).

    Article  CAS  PubMed  Google Scholar 

  20. Douglas, J.A. et al. Identifying susceptibility genes for prostate cancer–a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. Cancer Epidemiol. Biomarkers Prev. 14, 2035–2039 (2005).

    Article  CAS  PubMed  Google Scholar 

  21. Kong, A. & Cox, N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61, 1179–1188 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gudbjartsson, D.F., Jonasson, K., Frigge, M.L. & Kong, A. Allegro, a new computer program for multipoint linkage analysis. Nat. Genet. 25, 12–13 (2000).

    Article  CAS  PubMed  Google Scholar 

  23. Gretarsdottir, S. et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70, 593–603 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kong, A. et al. A high-resolution recombination map of the human genome. Nat. Genet. 31, 241–247 (2002).

    Article  CAS  PubMed  Google Scholar 

  25. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719–748 (1959).

    CAS  PubMed  Google Scholar 

  26. Grant, S.F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38, 320–323 (2006).

    Article  CAS  PubMed  Google Scholar 

  27. Boehnke, M. & Cox, N.J. Accurate inference of relationships in sib-pair linkage studies. Am. J. Hum. Genet. 61, 423–429 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Epstein, M.P., Duren, W.L. & Boehnke, M. Improved inference of relationship for pairs of individuals. Am. J. Hum. Genet. 67, 1219–1231 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


We thank the men with cancer and their family members whose contribution made this work possible. We also thank the nurses at Noatun and personnel at the deCODE core facilities for their hard work and enthusiasm. In addition, we thank the following individuals at the Department of Pathology at Landspitali University-Hospital for their contributions: A. Arason, G. Johannesdottir, K. Olafsdottir and S. Kristjansdottir. We also thank the staff at the Icelandic Cancer Registry for providing patient lists. We thank Regional Cancer Registries in Umeå, Uppsala, Stockholm-Gotland and Lindköping and all urologists who recruited their patients to this study and provided clinical data to the national registry of prostate cancer. We also thank P. Stattin, J. Adolfsson and E. Varenhorst as regional coordinators in CAPS and the personnel at the Medical Biobank in Umeå. The CAPS study has been supported by grants from the Swedish Cancer Foundation and partially funded by a US National Cancer Institute grant (CA 1R01CA105055-01A1). We also thank participants and clinicians at Northwestern University, the University of Chicago and the University of Michigan for their contribution to the collection of samples and clinical data used in this study.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Unnur Thorsteinsdottir or Kari Stefansson.

Ethics declarations

Competing interests

L.T.A., P.S., J.G., A.H., A.S., A.B., J.B.C., J.S., M.J., J.K., D.N.M., S.G., K.A., B.B., L.L.R., A.O., T.B., M.A., O.S.A., J.T.B., D.G., A.G., G.T., A.M., K.K., J.R.G., A.K., U.T. and K.S. own stock or stock options in deCODE genetics.

Supplementary information

Supplementary Fig. 1

A phylogenetic network of 46 SNPs and the DG8S737 microsatellite for the HapMap samples. (PDF 127 kb)

Supplementary Fig. 2

Linkage disequilibrium between the 17 SNPs and the –8 allele of DG8S737 typed in the CEU and the African American populations. (PDF 219 kb)

Supplementary Table 1

Markers and primers. (PDF 90 kb)

Supplementary Table 2

SNP markers genotyped in the 600-kb region on chromosome 8q24. (PDF 51 kb)

Supplementary Table 3

LD between the –8 allele of DG8S737 and allele A of rs1447295, and the 19 SNPs belonging to the equivalent class of rs1447295 in HapMap Caucasians (CEU). (PDF 65 kb)

Supplementary Table 4

Frequencies of haplotype groups (DG8S737 and rs1447295) in three Caucasian populations from Iceland, Sweden and the US. (PDF 54 kb)

Supplementary Table 5

The frequency of the various alleles of the microsatellite marker DS8S737 in the four populations studied. (PDF 26 kb)

Supplementary Table 6

Count of individuals and yields for DG8S737 and rs1447295 in the four study groups from Iceland, Sweden and the US. (PDF 59 kb)

Supplementary Table 7

Comparison of the relative risk of allele –8 of DG8S737 and allele A of rs1447295 under the multiplicative model with that of model-free estimates of the genotype relative risks of heterozygous carriers (0X), homozygous carriers (XX) and non-carriers (00). (PDF 82 kb)

Supplementary Methods (PDF 91 kb)

Supplementary Note (PDF 54 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amundadottir, L., Sulem, P., Gudmundsson, J. et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 38, 652–658 (2006).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing